FDA’s Stricter Covid Booster Standards Pose Strategic and Financial Challenges for Vaccine Makers Regulatory Shift: A New Era of Selective Covid Booster ApprovalsThe U.S. Food and Drug Administration (FDA) has introduced a new regulatory framework for Covid-19 vaccine boosters that marks a major departure from the previous “one-size-fits-all” approach. The agency will now require randomized, pla..
